Anxiolytics, adrenergic agents, and naltrexone

J Am Acad Child Adolesc Psychiatry
May 1999
https://pubmed.ncbi.nlm.nih.gov/10230186/

Etiological Pathways Toward Autism and Diversities of Treatments: From Unimodal to Multidimensional Approaches

Neuropsychoanalysis
February 2016
http://www.tandfonline.com/doi/abs/10.1080/15294145.2016.1156388

Naltrexone in young autistic children: replication study and learning measures

J Am Acad Child Adolesc Psychiatry
November 1997
https://www.ncbi.nlm.nih.gov/pubmed/?term=19393386

Objective: This study expanded upon previous work on naltrexone efficacy and safety in young autistic children and assessed performance on learning measures.

Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form
     in French

Encephale
April 2009
https://www.ncbi.nlm.nih.gov/pubmed/?term=19393386

Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone

Ann Ist Super Sanita
1996
https://www.ncbi.nlm.nih.gov/pubmed/?term=9028057

Novel and emerging treatments for autism spectrum disorders: a systematic review

Ann Clin Psychiatry
Oct-Dec 2009
https://www.ncbi.nlm.nih.gov/pubmed/?term=19917212

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study

Biol Psychiatry
June 1996
https://www.ncbi.nlm.nih.gov/pubmed/?term=8780837

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

J Child Adolesc Psychopharmacol
April 2008
https://www.ncbi.nlm.nih.gov/pubmed/?term=18439113

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study

J Am Acad Child Adolesc Psychiatry
February 1995
https://www.ncbi.nlm.nih.gov/pubmed/7896655

Objective: This study evaluated the efficacy and safety of naltrexone, an opiate blocker, in the treatment of autism.

Efficacy and safety of naltrexone use in pediatric patients with autistic disorder

Ann Pharmacother
June 2006
https://pubmed.ncbi.nlm.nih.gov/16735648/

Objective: To review the efficacy and safety of naltrexone in pediatric patients with autistic disorder (AD).